John F. Neylan

2015

In 2015, John F. Neylan earned a total compensation of $1.6M as Chief Medical Officer at Keryx Biopharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$49,900
Option Awards$769,140
Salary$266,154
Stock Awards$518,400
Total$1,603,594

Neylan received $769.1K in option awards, accounting for 48% of the total pay in 2015.

Neylan also received $49.9K in non-equity incentive plan, $266.2K in salary and $518.4K in stock awards.

Rankings

In 2015, John F. Neylan's compensation ranked 5,661st out of 13,638 executives tracked by ExecPay. In other words, Neylan earned more than 58.5% of executives.

ClassificationRankingPercentile
All
5,661
out of 13,638
59th
Division
Manufacturing
2,106
out of 5,187
59th
Major group
Chemicals And Allied Products
761
out of 1,857
59th
Industry group
Drugs
604
out of 1,531
61st
Industry
Pharmaceutical Preparations
472
out of 1,179
60th
Source: SEC filing on April 26, 2017.

Neylan's colleagues

We found five more compensation records of executives who worked with John F. Neylan at Keryx Biopharmaceuticals in 2015.

2015

Gregory Madison

Keryx Biopharmaceuticals

Chief Executive Officer

2015

Ron Bentsur

Keryx Biopharmaceuticals

Chief Executive Officer

2015

James Oliviero

Keryx Biopharmaceuticals

Chief Financial Officer

2015

Brian Adams

Keryx Biopharmaceuticals

General Counsel

2015

Scott Holmes

Keryx Biopharmaceuticals

Chief Financial Officer

You may also like